Press release
Small Interfering RNA (siRNA) Therapeutics Market Trends Analysis, Top Manufacturers, Shares, Growth Opportunities, Statistics & Forecast to 2026|
Key companies operating in the global Small Interfering RNA (siRNA) Therapeutics market include GE, Horizon Discovery, Thermo Scientific, OPKO Health, AInylam Pharmaceuticals, Arrowhead Research, Sanofi Genzyme, Genecon Biotechnologies, Arbutus Biopharma, Silent Therapeutics, Sylentis Small Interfering RNA (siRNA) Therapeutics
Get PDF Sample Copy of the Report to understand the structure of the complete report: (Including Full TOC, List of Tables & Figures, Chart) :
https://www.qyresearch.com/sample-form/form//1280950/global-small-interfering-rna-sirna-therapeutics-market
Segmental Analysis
The report has classified the global Small Interfering RNA (siRNA) Therapeutics industry into segments including product type and application. Every segment is evaluated based on growth rate and share. Besides, the analysts have studied the potential regions that may prove rewarding for the Small Interfering RNA (siRNA) Therapeutics manufcaturers in the coming years. The regional analysis includes reliable predictions on value and volume, thereby helping market players to gain deep insights into the overall Small Interfering RNA (siRNA) Therapeutics industry.
Global Small Interfering RNA (siRNA) Therapeutics Market Segment By Type:
, Liposome Based Systemic Therapy, Nanoparticle Based Systemic Therapy, Other Small Interfering RNA (siRNA) Therapeutics
Global Small Interfering RNA (siRNA) Therapeutics Market Segment By Application:
, Liposome Based Systemic Therapy, Nanoparticle Based Systemic Therapy, Other Small Interfering RNA (siRNA) Therapeutics
Competitive Landscape
It is important for every market participant to be familiar with the competitive scenario in the global Small Interfering RNA (siRNA) Therapeutics industry. In order to fulfil the requirements, the industry analysts have evaluated the strategic activities of the competitors to help the key players strengthen their foothold in the market and increase their competitiveness.
Key companies operating in the global Small Interfering RNA (siRNA) Therapeutics market include :GE, Horizon Discovery, Thermo Scientific, OPKO Health, AInylam Pharmaceuticals, Arrowhead Research, Sanofi Genzyme, Genecon Biotechnologies, Arbutus Biopharma, Silent Therapeutics, Sylentis Small Interfering RNA (siRNA) Therapeutics
Key questions answered in the report:
What is the growth potential of the Small Interfering RNA (siRNA) Therapeutics market?
Which product segment will grab a lion's share?
Which regional market will emerge as a frontrunner in coming years?
Which application segment will grow at a robust rate?
What are the growth opportunities that may emerge in Small Interfering RNA (siRNA) Therapeutics industry in the years to come?
What are the key challenges that the global Small Interfering RNA (siRNA) Therapeutics market may face in future?
Which are the leading companies in the global Small Interfering RNA (siRNA) Therapeutics market?
Which are the key trends positively impacting the market growth?
Which are the growth strategies considered by the players to sustain hold in the global Small Interfering RNA (siRNA) Therapeutics market?
Get Full Report in your inbox within 24 hours at USD(3900) : https://www.qyresearch.com/settlement/pre/04d3f6f5e284a822f084aa986b70c6ae,0,1,global-small-interfering-rna-sirna-therapeutics-market
TOC
Table of Contents 1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type
1.4.1 Global Small Interfering RNA (siRNA) Therapeutics Market Size Growth Rate by Type (2014-2025)
1.4.2 Liposome Based Systemic Therapy
1.4.3 Nanoparticle Based Systemic Therapy
1.4.4 Other
1.5 Market by Application
1.5.1 Global Small Interfering RNA (siRNA) Therapeutics Market Share by Application (2019-2025)
1.5.2 Hospital
1.5.3 Research Institutions
1.5.4 Pharmaceutical and Biotechnology Companies
1.5.5 Academic Institutions
1.5.6 Other
1.6 Study Objectives
1.7 Years Considered 2 Global Growth Trends
2.1 Small Interfering RNA (siRNA) Therapeutics Market Size
2.2 Small Interfering RNA (siRNA) Therapeutics Growth Trends by Regions
2.2.1 Small Interfering RNA (siRNA) Therapeutics Market Size by Regions (2019-2025)
2.2.2 Small Interfering RNA (siRNA) Therapeutics Market Share by Regions (2014-2019)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter's Five Forces Analysis 3 Market Share by Key Players
3.1 Small Interfering RNA (siRNA) Therapeutics Market Size by by Players
3.1.1 Global Small Interfering RNA (siRNA) Therapeutics Revenue by by Players (2014-2019)
3.1.2 Global Small Interfering RNA (siRNA) Therapeutics Revenue Market Share by by Players (2014-2019)
3.1.3 Global Small Interfering RNA (siRNA) Therapeutics Market Concentration Ratio (CR5 and HHI)
3.2 Small Interfering RNA (siRNA) Therapeutics Key Players Head office and Area Served
3.3 Key Players Small Interfering RNA (siRNA) Therapeutics Product/Solution/Service
3.4 Date of Enter into Small Interfering RNA (siRNA) Therapeutics Market
3.5 Mergers & Acquisitions, Expansion Plans 4 Breakdown Data by Type and Application
4.1 Global Small Interfering RNA (siRNA) Therapeutics Market Size by Type (2014-2019)
4.2 Global Small Interfering RNA (siRNA) Therapeutics Market Size by Application (2014-2019) 5 North America
5.1 North America Small Interfering RNA (siRNA) Therapeutics Market Size (2014-2019)
5.2 Small Interfering RNA (siRNA) Therapeutics Key Players in North America
5.3 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Type
5.4 North America Small Interfering RNA (siRNA) Therapeutics Market Size by Application 6 Europe
6.1 Europe Small Interfering RNA (siRNA) Therapeutics Market Size (2014-2019)
6.2 Small Interfering RNA (siRNA) Therapeutics Key Players in Europe
6.3 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Type
6.4 Europe Small Interfering RNA (siRNA) Therapeutics Market Size by Application 7 China
7.1 China Small Interfering RNA (siRNA) Therapeutics Market Size (2014-2019)
7.2 Small Interfering RNA (siRNA) Therapeutics Key Players in China
7.3 China Small Interfering RNA (siRNA) Therapeutics Market Size by Type
7.4 China Small Interfering RNA (siRNA) Therapeutics Market Size by Application 8 Japan
8.1 Japan Small Interfering RNA (siRNA) Therapeutics Market Size (2014-2019)
8.2 Small Interfering RNA (siRNA) Therapeutics Key Players in Japan
8.3 Japan Small Interfering RNA (siRNA) Therapeutics Market Size by Type
8.4 Japan Small Interfering RNA (siRNA) Therapeutics Market Size by Application 9 Southeast Asia
9.1 Southeast Asia Small Interfering RNA (siRNA) Therapeutics Market Size (2014-2019)
9.2 Small Interfering RNA (siRNA) Therapeutics Key Players in Southeast Asia
9.3 Southeast Asia Small Interfering RNA (siRNA) Therapeutics Market Size by Type
9.4 Southeast Asia Small Interfering RNA (siRNA) Therapeutics Market Size by Application 10 India
10.1 India Small Interfering RNA (siRNA) Therapeutics Market Size (2014-2019)
10.2 Small Interfering RNA (siRNA) Therapeutics Key Players in India
10.3 India Small Interfering RNA (siRNA) Therapeutics Market Size by Type
10.4 India Small Interfering RNA (siRNA) Therapeutics Market Size by Application 11 Central & South America
11.1 Central & South America Small Interfering RNA (siRNA) Therapeutics Market Size (2014-2019)
11.2 Small Interfering RNA (siRNA) Therapeutics Key Players in Central & South America
11.3 Central & South America Small Interfering RNA (siRNA) Therapeutics Market Size by Type
11.4 Central & South America Small Interfering RNA (siRNA) Therapeutics Market Size by Application 12 International Players Profiles
12.1 GE
12.1.1 GE Company Details
12.1.2 Company Description and Business Overview
12.1.3 Small Interfering RNA (siRNA) Therapeutics Introduction
12.1.4 GE Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2014-2019))
12.1.5 GE Recent Development
12.2 Horizon Discovery
12.2.1 Horizon Discovery Company Details
12.2.2 Company Description and Business Overview
12.2.3 Small Interfering RNA (siRNA) Therapeutics Introduction
12.2.4 Horizon Discovery Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2014-2019)
12.2.5 Horizon Discovery Recent Development
12.3 Thermo Scientific
12.3.1 Thermo Scientific Company Details
12.3.2 Company Description and Business Overview
12.3.3 Small Interfering RNA (siRNA) Therapeutics Introduction
12.3.4 Thermo Scientific Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2014-2019)
12.3.5 Thermo Scientific Recent Development
12.4 OPKO Health
12.4.1 OPKO Health Company Details
12.4.2 Company Description and Business Overview
12.4.3 Small Interfering RNA (siRNA) Therapeutics Introduction
12.4.4 OPKO Health Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2014-2019)
12.4.5 OPKO Health Recent Development
12.5 AInylam Pharmaceuticals
12.5.1 AInylam Pharmaceuticals Company Details
12.5.2 Company Description and Business Overview
12.5.3 Small Interfering RNA (siRNA) Therapeutics Introduction
12.5.4 AInylam Pharmaceuticals Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2014-2019)
12.5.5 AInylam Pharmaceuticals Recent Development
12.6 Arrowhead Research
12.6.1 Arrowhead Research Company Details
12.6.2 Company Description and Business Overview
12.6.3 Small Interfering RNA (siRNA) Therapeutics Introduction
12.6.4 Arrowhead Research Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2014-2019)
12.6.5 Arrowhead Research Recent Development
12.7 Sanofi Genzyme
12.7.1 Sanofi Genzyme Company Details
12.7.2 Company Description and Business Overview
12.7.3 Small Interfering RNA (siRNA) Therapeutics Introduction
12.7.4 Sanofi Genzyme Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2014-2019)
12.7.5 Sanofi Genzyme Recent Development
12.8 Genecon Biotechnologies
12.8.1 Genecon Biotechnologies Company Details
12.8.2 Company Description and Business Overview
12.8.3 Small Interfering RNA (siRNA) Therapeutics Introduction
12.8.4 Genecon Biotechnologies Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2014-2019)
12.8.5 Genecon Biotechnologies Recent Development
12.9 Arbutus Biopharma
12.9.1 Arbutus Biopharma Company Details
12.9.2 Company Description and Business Overview
12.9.3 Small Interfering RNA (siRNA) Therapeutics Introduction
12.9.4 Arbutus Biopharma Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2014-2019)
12.9.5 Arbutus Biopharma Recent Development
12.10 Silent Therapeutics
12.10.1 Silent Therapeutics Company Details
12.10.2 Company Description and Business Overview
12.10.3 Small Interfering RNA (siRNA) Therapeutics Introduction
12.10.4 Silent Therapeutics Revenue in Small Interfering RNA (siRNA) Therapeutics Business (2014-2019)
12.10.5 Silent Therapeutics Recent Development
12.11 Sylentis 13 Market Forecast 2019-2025
13.1 Market Size Forecast by Product (2019-2025)
13.2 Market Size Forecast by Application (2019-2025)
13.3 Market Size Forecast by Regions
13.4 North America
13.5 Europe
13.6 China
13.7 Japan
13.8 Southeast Asia
13.9 India
13.10 Central & South America 14 Analyst's Viewpoints/Conclusions 15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Disclaimer
15.3 Author Details
About Us:
QYResearch always pursuits high product quality with the belief that quality is the soul of business. Through years of effort and supports from huge number of customer supports, QYResearch consulting group has accumulated creative design methods on many high-quality markets investigation and research team with rich experience. Today, QYResearch has become the brand of quality assurance in consulting industry.
Contact Us:-
QY Research, INC.
17890 Castleton,
Suite 218,
Los Angeles, CA - 91748
USA: +1 626 295 2442
Email:
enquiry@qyresearch.com
Web:
http://www.qyresearch.com
-
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Small Interfering RNA (siRNA) Therapeutics Market Trends Analysis, Top Manufacturers, Shares, Growth Opportunities, Statistics & Forecast to 2026| here
News-ID: 2025895 • Views: …
More Releases from QY Research
Global and U.S. Hydrogen Odorants Market Report, Published by QY Research.
Hydrogen Odorants are chemical additives introduced into hydrogen gas streams to impart a detectable smell for leak detection and safety monitoring, since pure hydrogen is colorless and odorless. Effective odorants must provide distinct olfactory signals at very low concentrations, while maintaining compatibility with fuel cells, pipelines, and storage systems. Common candidates include sulfur-free organic compounds, terpenes, and nitrogen-containing molecules, developed as alternatives to natural gas odorants to prevent catalyst poisoning…
Global and U.S. 3-point / 4-point Bend Fixtures Market Report, Published by QY R …
3-point and 4-point Bend Fixtures are mechanical test assemblies designed to evaluate the flexural strength, stiffness, and fracture behavior of materials under bending loads. In a 3-point setup, the specimen is supported at two points with a single load applied at the midpoint, while the 4-point configuration distributes the load between two points for a more uniform stress region. These fixtures are widely used for plastics, composites, ceramics, metals, and…
Global and U.S. High Speed Flatbed Scanners Market Report, Published by QY Resea …
High Speed Flatbed Scanners are digital imaging devices designed to capture high-resolution scans of documents, photos, and bound materials with rapid throughput compared to standard flatbed units. Featuring advanced CCD/CIS sensors, duplex scanning, and automatic image correction software, they are essential for businesses, government agencies, libraries, and archival institutions managing large volumes of physical records.
https://www.qyresearch.com/reports/4942701/high-speed-flatbed-scanners
The global High Speed Flatbed Scanners market reached USD 2.2 billion in 2024, growing at a…
Steel Floor Panels Market to Reach USD 17,565 Million by 2031 Top 20 Company Glo …
Steel floor panels cover a range of products used in commercial, industrial and data-center construction: profiled steel decking for composite slabs, galvanized or coated steel raised-access panels for server rooms and offices, and engineered steel mezzanine/industrial floor panels for warehouses and manufacturing plants. They are selected for strength-to-weight ratio, speed of installation, fire performance (when specified with appropriate infill), recyclability and long service life. Product differentiation is driven by profile…
More Releases for RNA
CD Formulation Launches Custom Circular RNA Synthesis Service to Accelerate RNA …
CD Formulation introduces a customizable circRNA synthesis service, delivering high-quality, stable circRNAs for therapeutics, vaccines, and gene research, supported by advanced design and QC processes.
CD Formulation, a leading provider of advanced small nucleic acid synthesis [https://www.formulationbio.com/nucleic-acid/custom-small-nucleic-acid-synthesis.html] solutions, is proud to announce the launch of its fully customizable circular RNA (circRNA) synthesis service. This new service addresses the growing need for stable, non-immunogenic RNA molecules for therapeutic development, vaccine research, and…
Self-Amplifying RNA Synthesis Market Gains Traction as Biotech Firms Embrace Sca …
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the " Self-Amplifying RNA Synthesis Market- (By Product & Service (Products (Enzymes & Reagents, Premade saRNA, Others), Custom Synthesis Services), By Application (Therapeutics Development (Oncology, Infectious Diseases, Others), Biomedical Research), By End-User (Pharmaceutical & Biotechnology Companies, Academic & Research Institutes, Others)), Trends, Industry Competition Analysis, Revenue and Forecast To 2034."
According to the latest research by InsightAce Analytic,…
RNA Extraction and RNA Purification Market: Growth, Trends & Competitive Landsca …
The global RNA Extraction and RNA Purification Market is expected to grow at 6.3% CAGR from 2025 to 2032.
This Market Report is the result of extensive research and analysis conducted by our team of experienced market researchers through -
• 70% efforts of Primary Research
• 15% efforts of Secondary Research
• 15% efforts from the subscription to Paid database providing industry overview, macro and micro economics factors, and financials of private limited…
RNA Targeting Small Molecules Therapeutics Market: Exponential Growth with Risin …
Estimations Predict a CAGR of 29.8% by 2029 in Global RNA Targeting Small Molecules Therapeutics Market Boosted by Precision Medicine, RNA Biomarker Identification and RNA Genetic Manipulation
What Is The Projected Market Size of The Global RNA Targeting Small Molecules Therapeutics Market And Its Growth Rate?
• The market will grow from $6.1 billion in 2024 to $7.87 billion in 2025 at a compound annual growth rate (CAGR) of 28.9%.
• Expected exponential…
Global DNARNA Extraction Kit Market by Type (Cell-free DNA (cfDNA), Sequence-spe …
"DNARNA Extraction Kit Market" is segmented by Company, Region (country), By Type, Application, stakeholders and other participants. This report provides an analysis of revenue and forecast across Type and Application segments for 2023-2032.
The market for DNARNA Extraction Kits has been thoroughly researched via primary and secondary sources to produce this research study. Along with a competitive analysis of the market, segmented by application, type, and geographical trends, it offers a…
Cancer RNA Expression Market to Reap Excessive Revenues by 2028(By sequencing te …
Worldwide cancer is one of the leading cause of death and effective way of treating it still looks unaccomplished in most parts of the world. The factors which influence the successful treatment of cancer are different depending on the stage of diagnosis, treatment availability and availability of trained healthcare professionals coupled with high economic burden of the disease. The gene expression of cancerous cells varies by cancer type and may…
